Overview

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Status:
Not yet recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
A Phase 1, Single Dose, Open-label, Safety, Tolerability, and Pharmacokinetic Study of LYN-014 in Individuals with Opioid Use Disorder Who are Stable on Methadone Therapy
Phase:
Phase 1
Details
Lead Sponsor:
Lyndra Inc.
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Methadone
Morphine